Psoriasis Completed Phase 1 / 2 Trials for Cyclosporine (DB00091)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00050648To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis VulgarisTreatment
NCT00578370Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque TestTreatment